Filix Medtech is a startup striving to add value to the Chinese Medicines and related Health Supplement products supply chain through traceable and verifiable technology. Currently, Chinese Medicines product has certain quality issues especially for those selling in raw form in which authentication of those products will require expensive laboratory equipment and this is also time consuming. So we are engaging Distributed Ledger Technology (DLT) for product traceability in various stages of the supply chain together with mobile Near-Infra-Red (NIR) spectroscopy technology with Computer Vision (VIS) and advanced data analytics to facilitate on-spot verification of Chinese Medicines products. Initially, our target market will be B2B and targeted for Chinese Medicines manufacturer in Hong Kong. And then we will migrate to the B2B2C health products platform targeted for health conscious consumers market. Eventually, we will then explore the Greater Bay Area or Asia market and beyond.